|
|
|
24.06.25 - 10:48
|
Hims & Hers Health Aktie stürzt ab - Novo-Aus erhöht Klagegefahr (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von der Citigroup:
Die Analysten der Citigroup raten die Aktie von Hims & Hers Health Inc. (ISIN: US4330001060, WKN: A2QMYY, Ticker-Symbol: 82W, NYSE-Symbol: HIMS) weiterhin zu verkaufen.
Nach nur einem Monat habe Novo Nordisk bekannt gegeben, dass es die Partnerschaft mit Hims & Hers zur direkten Bereitstellung von Wegovy über NovoCare beende. [mehr]...
|
|
|
24.06.25 - 09:54
|
Tesla startet Robotaxi-Dienst - Novo Nordisk beendet Partnerschaft mit Hims & Hers (Aktiencheck)
|
|
|
Wien (www.aktiencheck.de) - Der Elektroautobauer Tesla (+8,2%) startete den von Firmenchef Elon Musk seit langem angekündigten Robotaxi-Dienst - allerdings zunächst im Kleinformat und mit einem menschlichen Aufpasser auf dem Beifahrersitz, so die Analysten der Raiffeisen Bank International AG (RBI).
In Austin könnten ausgewählte Nutzer seit Sonntag per App Fahrten in einigen Wagen ohne einen Menschen am Steuer buchen. [mehr]...
|
|
|
|
|
|
|
23.06.25 - 16:15
|
Major shareholder announcement (GlobeNewswire EN)
|
|
|
In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces thatBlackRock, Inc. has notified the company that it now holds 7,519,559 shares, corresponding to 9.51% of the total voting rights and share capital (previously 9.5%). Additionally, BlackRock, Inc. controls voting rights attached to financial instruments amounting to 0.49% (previously 0.49%). In total, BlackRock, Inc. control 10.01% of the company's voting rights (previously 9.99%)....
|
|
|
|
|
|
|
|
|
|
|
23.06.25 - 08:45
|
Share repurchase programme: Transactions of week 25 2025 (GlobeNewswire EN)
|
|
|
The share repurchase programme runs as from 26 February 2025 and up to and including 30 January 2026 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 2.25 billion, cf. Corporate Announcement No. 3/2025 of 26 February 2025. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called “Market Abuse Regulation”, and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the "Safe Harbour Rules")....
|
|
|
20.06.25 - 14:15
|
Hims & Hers Health Aktie: 130% Plus - dank Novo Nordisk-Deal und Amazon-Manager (Aktiencheck)
|
|
|
Paris (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse der BNP Paribas:
Der US-Telemedizin-Anbieter Hims & Hers Health Inc. (ISIN: US4330001060, WKN: A2QMYY, Ticker-Symbol: 82W, NYSE-Symbol: HIMS) hat eine Kooperation mit Novo Nordisk geschlossen, zudem lässt die Neueinstellung eines ehemaligen Amazon-Managers aufhorchen, so Egmond Haidt, Finanzjournalist, in einer aktuellen Veröffentlichung bei BNP Paribas. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
17.06.25 - 14:03
|
Tryg Analyst Day 2025 (GlobeNewswire EN)
|
|
|
Tryg is hosting its Analyst Day 2025 today at Tryg's headquarters. The event is dedicated to the sell-side analysts that cover the share. No new financial or strategic targets will be revealed - presentations from different business units will be shown. The presentation can be found on Tryg.com or attached here....
|
|
|
|
|
16.06.25 - 12:03
|
Tryg - Transactions in connection with share buyback programme (GlobeNewswire EN)
|
|
|
On 04 December 2024, Tryg A/S (“Tryg”) announced that the Board of Directors had decided to initiate a share buyback programme of up to DKK 2.0 billion. The share buyback programme is executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Regulation”). The share buyback programme will end no later than 30 June 2025....
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
